Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Smeitink

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|March 26, 2010
Metabolism, gliomas, and IDH1Jan Smeitink
Journal of Inherited Metabolic Disease|March 3, 2011
Mitochondrial medicineSaskia Koene, Jan Smeitink
Journal of Inherited Metabolic Disease|July 30, 2010
Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunctionSaskia Koene, Jan Smeitink
Biochimica Et Biophysica Acta|November 26, 2009
Mitochondrial disease-the ever-widening circleHowy Jacobs, Jan Smeitink
Methods (San Diego, Calif.)|October 25, 2008
Electrophoresis techniques to investigate defects in oxidative phosphorylationMaria Antonietta Calvaruso, Jan Smeitink, Leo Nijtmans
Acta Neuropathologica|June 28, 2005
Unusual features of mitochondrial degeneration in skeletal muscle of patients with nuclear complex I mutationArgirios Dinopoulos, Jan Smeitink, Henk ter Laak
Journal of Biomedicine & Biotechnology|April 17, 2010
Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficienciesPaulien Smits, Jan Smeitink, Lambert van den Heuvel
Plos One|July 9, 2021
Sonlicromanol's active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growthXiaolan Jiang, Herma Renkema, Jan Smeitink, et al.
The International Journal of Biochemistry & Cell Biology|February 11, 2015
Mitochondrial diseases: Drosophila melanogaster as a model to evaluate potential therapeuticsSarah Foriel, Peter Willems, Jan Smeitink, et al.
Human Genetics|April 6, 2002
CIA30 complex I assembly factor: a candidate for human complex I deficiency?Rolf Janssen, Jan Smeitink, Roel Smeets, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|March 26, 2010
Metabolism, gliomas, and IDH1Jan Smeitink
Journal of Inherited Metabolic Disease|March 3, 2011
Mitochondrial medicineSaskia Koene, Jan Smeitink
Journal of Inherited Metabolic Disease|July 30, 2010
Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunctionSaskia Koene, Jan Smeitink
Biochimica Et Biophysica Acta|November 26, 2009
Mitochondrial disease-the ever-widening circleHowy Jacobs, Jan Smeitink
Methods (San Diego, Calif.)|October 25, 2008
Electrophoresis techniques to investigate defects in oxidative phosphorylationMaria Antonietta Calvaruso, Jan Smeitink, Leo Nijtmans
Acta Neuropathologica|June 28, 2005
Unusual features of mitochondrial degeneration in skeletal muscle of patients with nuclear complex I mutationArgirios Dinopoulos, Jan Smeitink, Henk ter Laak
Journal of Biomedicine & Biotechnology|April 17, 2010
Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficienciesPaulien Smits, Jan Smeitink, Lambert van den Heuvel
Plos One|July 9, 2021
Sonlicromanol's active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growthXiaolan Jiang, Herma Renkema, Jan Smeitink, et al.
The International Journal of Biochemistry & Cell Biology|February 11, 2015
Mitochondrial diseases: Drosophila melanogaster as a model to evaluate potential therapeuticsSarah Foriel, Peter Willems, Jan Smeitink, et al.
Human Genetics|April 6, 2002
CIA30 complex I assembly factor: a candidate for human complex I deficiency?Rolf Janssen, Jan Smeitink, Roel Smeets, et al.
Pageof 8